Executive MBA Alumna Appointed Head of Astellas Global Medical Affairs
Astellas Hires Senior Vice President of New Global Medical Affairs Organization
Deerfield, Ill./February 21, 2012 – Astellas Scientific and Medical Affairs announces Charlotte M. E. Kremer, MD, MBA has joined the company as the head of one of the Company’s newest organizations – Global Medical Affairs (GMA). In this new role, Dr. Kremer will provide global leadership for medical excellence and a unified medical perspective across regions for Astellas’ portfolio of global products.
“We are thrilled to have Charlotte join Astellas. She brings years of experience and an outstanding reputation to this new, global leadership role,” said Yoshihiko Hatanaka, president and CEO of Astellas Pharma Inc., the parent company of Astellas US LLC.
Dr. Kremer comes to Astellas with 20 years experience in the pharmaceutical industry. Most recently, Dr. Kremer held the position of Vice President, Therapeutic Area Head for Ophthalmology, PVD, Rare Diseases and Neuroscience at Pfizer. While at Pfizer, she successfully led and executed the clinical development and global medical strategy in these respective areas. Prior to joining Pfizer, Dr. Kremer held positions of increasing responsibility providing medical support, developing Phase IIIB/IV clinical trials, and initiating and directing a Medical Liaison program at Organon Pharmaceuticals, both in the Netherlands and in the United States.
A native of the Netherlands, Dr. Kremer received her undergraduate and medical degrees from the University of Utrecht, The Netherlands. She went on to receive her Diploma Pharmaceutical Medicine (DPM) from Universite Libre de Bruxelles. After transferring to the United States, Dr. Kremer completed the Executive MBA program at New York University’s Leonard N. Stern School of Business.
“We are thrilled to have Charlotte join Astellas. She brings years of experience and an outstanding reputation to this new, global leadership role,” said Yoshihiko Hatanaka, president and CEO of Astellas Pharma Inc., the parent company of Astellas US LLC.
Dr. Kremer comes to Astellas with 20 years experience in the pharmaceutical industry. Most recently, Dr. Kremer held the position of Vice President, Therapeutic Area Head for Ophthalmology, PVD, Rare Diseases and Neuroscience at Pfizer. While at Pfizer, she successfully led and executed the clinical development and global medical strategy in these respective areas. Prior to joining Pfizer, Dr. Kremer held positions of increasing responsibility providing medical support, developing Phase IIIB/IV clinical trials, and initiating and directing a Medical Liaison program at Organon Pharmaceuticals, both in the Netherlands and in the United States.
A native of the Netherlands, Dr. Kremer received her undergraduate and medical degrees from the University of Utrecht, The Netherlands. She went on to receive her Diploma Pharmaceutical Medicine (DPM) from Universite Libre de Bruxelles. After transferring to the United States, Dr. Kremer completed the Executive MBA program at New York University’s Leonard N. Stern School of Business.
Charlotte M. E. Kremer, MD, MBA